Seoul, South Korea

Sunoh Kim

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Korea Institute of Science and Technology. Active years: 2006.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sunoh Kim: Innovator in Cell Line Development

Introduction

Sunoh Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of molecular biology through his innovative research and development of cell lines. His work is particularly focused on enhancing the understanding of cellular signaling pathways.

Latest Patents

Sunoh Kim holds a patent for a cell line that is prepared by transforming HEK293 cells with a human Kir2.1 gene using a retrovirus expression system. This cell line expresses a stable αT-type calcium channel, which allows it to respond sensitively to KCl. The development of this cell line enables researchers to investigate cellular signaling pathways through molecular biological and biochemical studies.

Career Highlights

Sunoh Kim is affiliated with the Korea Institute of Science and Technology, where he continues to advance his research. His work has garnered attention for its potential applications in various scientific fields, particularly in understanding cellular mechanisms.

Collaborations

Sunoh Kim has collaborated with notable colleagues, including Taehyun Kim and Dae-Sik Lim. These collaborations have further enriched his research and contributed to the advancement of their shared scientific goals.

Conclusion

Sunoh Kim is a dedicated inventor whose work in cell line development has the potential to significantly impact molecular biology research. His innovative approach and collaboration with esteemed colleagues highlight his commitment to advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…